Topic positron emission tomography

News positron emission tomography

• Oxford BioMedica Announces 5T4 Antibody Research Collaboration with ImaginAb

  Oxford BioMedica plc  announced that it has signed a research collaboration agreement with ImaginAb, Inc., a biotechnology company specialising in the development of engineered antibody fragments for diagnostic imaging and  therapeutic applications, to engineer an in vivo diagnostic imaging agent us more

• BioInvent announces approval to start Phase II trial for its novel cardiovascular drug BI-204

  BioInvent International AB announced IND clearance from the U.S. Food & Drug Administration (FDA) to initiate a Phase II study for BI-204. BI-204 is a human monoclonal antibody that specifically targets oxidized forms of a low-density lipoprotein (LDL) which has been linked to increased inflammatory more

• Mount Sinai researchers find potential therapeutic target across a range of cancer types

  Researchers from Mount Sinai School of Medicine, in collaboration with investigators of the National Institute of Health and Medical Research (INSERM) of France led by Nicolae Ghinea, PhD, have found a common link among several malignant tumor types in all grades of cancer. This breakthrough may ult more

Publications positron emission tomography

• Correlation between crossed cerebellar diaschisis and clinical neurological scales

  Szilágyi G, Vas Á, Kerényi L, Nagy Z, Csiba L, Gulyás B. Correlation between crossed cerebellar diaschisis and clinical neurological scales. 
Acta Neurol Scand: 2012: 125: 373–381. 
© 2011 John Wiley & Sons A/S. Background –  A common consequence of unilateral stroke is crossed cerebellar diasc more

• Simultaneous measurement of extracellular dopamine and dopamine transporter occupancy by cocaine analogs in squirrel monkeys

  Abstract Several classes of drugs bind to the dopamine transporter (DAT) with high affinity, but some are weaker positive reinforcers than cocaine, suggesting that affinity for and occupancy of the DAT is not the only determinant of a drug's reinforcing effectiveness. Other factors such as the ra more

• Affinity and selectivity of [11C]‐(+)‐PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo

  Abstract Although [11C]‐(+)‐PHNO has enabled quantification of the dopamine‐D3 receptor (D3R) in the human brain in vivo, its selectivity for the D3R is not sufficiently high to allow us to disregard its binding to the dopamine‐D2 receptor (D2R). We quantified the affinity of [11C]‐(+)‐PHNO for t more

Market studies positron emission tomography

• Diagnostic Imaging Market to 2017 - Fusion Technology to Increase Adoption Rates of Hybrid Imaging Systems

  GBI Research’s report, “Diagnostic Imaging Market to 2017 - Fusion Technology to Increase Adoption Rates of Hybrid Imaging Systems” provides information and analysis on the global diagnostic imaging market. The report provides market landscape, competitive landscape and market trends information on more

• Diagnostic Imaging International Corp. - Strategic SWOT Analysis Review

  Diagnostic Imaging International Corp. (DIIC) is a US based medical device company. The company was formerly known as Galloway Investments Corp. It is a development-stage company planning to acquire and operate diagnostic imaging clinics including Magnetic Resonance Imaging (MRI) clinics, Computed T more

• Positron Corporation (POSC) - Financial and Strategic SWOT Analysis Review

  Positron Corporation (POSC) - Financial and Strategic SWOT Analysis Review Summary Positron Corporation (Positron) is a molecular imaging company. It is engaged in the development, manufacture and distribution of medical imaging systems for diagnostic markets. It develops molecular imaging systems more

Websites positron emission tomography